Home > Gastrointestinal Oncology > Pancreatic Cancer
    Content Type:
  • Pancreatic Cancer

    An Introduction to Pancreatic Cancer

    Pancreatic cancer is one of the most devastating malignancies worldwide, with a 5-year overall survival of less than 8%. Surgical resection followed by adjuvant chemotherapy is currently the only curative therapy available, but only 10-20% of patients present with resectable disease. At present, combined approaches involving radiotherapy in conjunction with targeted therapies or immunotherapies offer the best outcomes. However, advances in sequencing technologies have enabled a detailed analysis of genetic alterations, mutational burden, expression pattern, and stroma composition and identified disease subtypes, which will hopefully translate into novel therapeutic approaches.

    Browse the content below where leading experts, discuss the latest data in video interviews and short articles from our conference hub and browse the selection of peer-reviewed articles from our journal portfolio. If you’re looking to learn more about the impact of these developments on patient outcomes, our educational activities are a great resource.

    Pancreatic Cancer Content

    Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greyarrow-right-orangearrow-right-whitearrow-right-blueavatarcalendarchevron-down crosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmenumore_dots padlock person play_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar